Disease Control and Prevention Vaccine Market - Global Forecast, 2022 - 2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	210 Pages	Coherent Market Insights	May, 2022	CMI17211259

Best Price Guarantee
Price	from $4,500
Length	210 Pages
Publisher	Coherent Market Insights
Published Date	May, 2022
SKU	CMI17211259

Disease Control and Prevention Vaccine Market - Global Forecast, 2022 - 2028

Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
Market Dynamics
The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.
Key features of the study:

This report provides in-depth analysis of the disease control and prevention vaccine market and its Type, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global disease control and prevention vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:

Global Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Global Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Global Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Global Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Global Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Global Disease Control and Prevention Vaccine Market, By Region:

North America

U.S.

U.S. Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

U.S. Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

U.S. Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

U.S. Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

U.S. Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Canada

Canada Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Canada Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Canada Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Canada Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Canada Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Europe

U.K.

U.K. Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

U.K. Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

U.K. Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

U.K. Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

U.K. Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Germany

Germany Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Germany Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Germany Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Germany Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Germany Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Italy

Italy Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Italy Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Italy Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Italy Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Italy Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

France

France Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

France Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

France Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

France Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

France Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Spain

Spain Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Spain Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Spain Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Spain Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Spain Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Russia

Russia Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Russia Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Russia Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Russia Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Russia Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Rest of Europe

Rest of Europe Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Rest of Europe Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Rest of Europe Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Rest of Europe Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Rest of Europe Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Asia-Pacific

China

China Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

China Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

China Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

China Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

China Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

India

India Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

India Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

India Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

India Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

India Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Japan

Japan Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Japan Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Japan Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Japan Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Japan Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

ASEAN

ASEAN Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

ASEAN Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

ASEAN Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

ASEAN Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

ASEAN Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Australia

Australia Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Australia Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Australia Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Australia Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Australia Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

South Korea

South Korea Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

South Korea Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

South Korea Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

South Korea Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

South Korea Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Rest of Asia Pacific

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Latin America

Brazil

Brazil Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Brazil Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Brazil Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Brazil Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Brazil Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Mexico

Mexico Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Mexico Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Mexico Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Mexico Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Mexico Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Rest of Latin America

Rest of Latin America Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Rest of Latin America Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Rest of Latin America Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Rest of Latin America Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Rest of Latin America Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Middle East

GCC

GCC Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

GCC Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

GCC Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

GCC Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

GCC Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Israel

Israel Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Israel Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Israel Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Israel Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Israel Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Rest of Middle East

Rest of Middle East Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Rest of Middle East Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Rest of Middle East Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Rest of Middle East Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Rest of Middle East Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Africa

North Africa

North Africa Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

North Africa Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

North Africa Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

North Africa Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

North Africa Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Central Africa

Central Africa Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

Central Africa Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

Central Africa Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

Central Africa Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

Central Africa Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

South Africa

South Africa Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines

South Africa Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine
Multivalent Vaccine

South Africa Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral
Injectable

South Africa Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric
Adults

South Africa Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease
Cancer
Other Indication

Company Profiles

GlaxoSmithKline plc (GSK) *

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Merck & Co. Inc.
Sanofi
AstraZeneca PLC
Pfizer, Inc.
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd.
Astellas Pharma Inc.
Daiichi Sankyo

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption: Research Objectives; Assumptions; Abbreviations
2. Market Overview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Product Type; Market Snippet, By Type; Market Snippet, By Route of Administration; Market Snippet, By Age Group; Market Snippet, By Indication; Market Snippet, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Governmental Initiative; Product Pipeline; Regulatory Landscape; PEST Analysis; PORTER’S Five Forces
4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2017 - 2028, (US$ Million): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Live-attenuated Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Inactivated Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Recombinant Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Toxoid Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Disease Control and Prevention Vaccines Market, By Type, 2017 - 2028, (US$ Million): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Monovalent Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Multivalent Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2017 - 2028, (US$ Million): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Oral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Injectable; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2017 - 2028, (US$ Million): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Pediatric Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Adult Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Disease Control and Prevention Vaccines Market, By Indication, 2017 - 2028, (US$ Million): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Infectious Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Other Indications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
9. Global Disease Control and Prevention Vaccines Market, By Regions, 2017 - 2028, (US$ Million): Introduction; Market Share Analysis, By Region, 2022 and 2028 (%); Y-o-Y Growth Analysis, By Region, 2017 - 2028; Regional Trends; North America; U.S.; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Canada; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Europe; U.K.; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Germany; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Italy; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); France; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Spain; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Russia; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Rest of Europe; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Asia Pacific; China; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Japan; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); India; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); ASEAN; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Australia; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); South Korea; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Rest of Asia Pacific; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Latin America; Brazil; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Mexico; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Rest of Latin America; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Africa; Northern Africa; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Central Africa; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); South Africa; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Middle East; GCC Countries; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Israel; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Rest of Middle East; Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million); Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
10. Competitive Landscape: Heat Map Analysis; Company Profiles; GlaxoSmithKline plc (GSK); Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Merck & Co. Inc.; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Sanofi; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; AstraZeneca PLC; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Pfizer, Inc.; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Serum Institute of India Pvt. Ltd.; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Sinovac Biotech Ltd.; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Astellas Pharma Inc.; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Daiichi Sankyo; Company Overview; Product Portfolio; Financial Performance; Recent Highlights; Strategies; Analyst Views
11. Section: References; Research Methodology; About Us and Sales Contact; *Browse 47 market data tables and 45 figures on "Disease Control and Prevention Vaccines Market - Global forecast to 2028”.